About The Second Affiliated Hospital of Nanjing Medical University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
14
Bayer
4
The Second Hospital of Nanjing Medical University
4
Xiamen Amoytop Biotech Co., Ltd.
4
Nanfang Hospital of Southern Medical University
3
Sunshine Lake Pharma Co., Ltd.
3
Beijing Kawin Technology Share-Holding Co., Ltd.
2
Jiangsu Hansoh Pharmaceutical Co., Ltd.
2
Jiangsu Simcere Pharmaceutical Co., Ltd.
2
Jinling Hospital, China
2
Shanghai Public Health Clinical Center
2
Clinical Trials at The Second Affiliated Hospital of Nanjing Medical University
During the past decade, The Second Affiliated Hospital of Nanjing Medical University conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 6 clinical trials were completed, i.e. on
average, 9.8% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 5 clinical trials were completed. i.e. 15.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
2010-07-01
2012-03-01
Completed
211
Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
2010-07-01
2012-04-01
Completed
205
Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients
2010-06-01
2014-01-01
Completed
378
Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients
2012-04-01
2014-06-01
Completed
770
Danhong Injection in the Treatment of Acute Ischemic Stroke
2013-03-13
2019-03-27
Completed
1,503
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
2013-03-01
2015-08-01
Completed
820
Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury
2013-03-01
2014-08-01
Unknown status
2,040
Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C
2013-06-01
2015-08-01
Completed
719
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Second Affiliated Hospital of Nanjing Medical University" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "Bayer" with 4 trials
sponsored, "The Second Hospital of Nanjing Medical University" with 4 trials sponsored, "Xiamen Amoytop Biotech Co., Ltd." with 4 trials sponsored and "Nanfang Hospital of Southern Medical University"
with 4 trials sponsored. Other sponsors include 43 different institutions and
companies that sponsored additional 46 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Nanjing Medical University"
#1 collaborator was "The Second Hospital of Nanjing Medical University" with 3 trials as a collaborator, "Tigermed Consulting Co., Ltd" with 3 trials as a collaborator, "Jiangsu Yuyue medical equipment & supply Co., Ltd." with 2 trials as a collaborator, "Nanjing Medical University" with 2 trials as a collaborator and "Peking University First Hospital" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were
collaborators in the rest 27 trials.
Clinical Trials Conditions at The Second Affiliated Hospital of Nanjing Medical University
According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Nanjing Medical University" are
"Hepatitis B, Chronic" (7 trials), "Chronic Hepatitis B" (6 trials), "Obesity" (6 trials), "Type 2 Diabetes" (4 trials) and "Chronic Hepatitis C" (3 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Nanjing Medical University" in a lesser frequency.
Clinical Trials Intervention Types at The Second Affiliated Hospital of Nanjing Medical University
Most popular intervention types in "The Second Affiliated Hospital of Nanjing Medical University" are "Drug" (60 trials), "Other" (6 trials), "Procedure" (5 trials), "Device" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "Tirzepatide" (7 trials), "Ypeginterferon alfa-2b" (4 trials), "Lamivudine" (3 trials) and "Adefovir" (2 trials). Other intervention names were less common.
Clinical Trials Genders at The Second Affiliated Hospital of Nanjing Medical University
The vast majority of trials in "The Second Affiliated Hospital of Nanjing Medical University" are
73 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at The Second Affiliated Hospital of Nanjing Medical University
Currently, there are NaN active trials in "The Second Affiliated Hospital of Nanjing Medical University".
3 are not yet recruiting,
14 are recruiting,
10 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 35 completed trials in The Second Affiliated Hospital of Nanjing Medical University,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Second Affiliated Hospital of Nanjing Medical University, 0 "Phase 1"
clinical trials were conducted, 17 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 7 trials, and there were
also 12 trials that are defined as “Not Applicable".